Related Experiment Video
Updated: Apr 16, 2026
10:05
Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
8.8K
Small targeted cytotoxics from DNA-encoded chemical libraries
1Philochem AG, Libernstrasse 3, CH8112, Otelfingen (ZH), Switzerland.
Current Opinion in Chemical Biology
|March 3, 2015
Summary
Targeted cancer therapies using small molecules offer advantages over traditional chemotherapy. DNA-encoded chemical libraries enable the discovery of high-affinity ligands for next-generation targeted cytotoxics.
Area of Science:
- Drug Discovery
- Oncology
- Molecular Biology
Background:
- Conventional chemotherapy lacks tumor selectivity, causing toxicity and limiting dosage.
- Targeted delivery of potent molecules to disease sites is a promising therapeutic strategy.
- Antibodies are common delivery vehicles, but small molecule ligands offer potential advantages.
Purpose of the Study:
- To explore the potential of low molecular weight ligands for targeted therapeutics.
- To address the challenge of identifying high-affinity, specific binding molecules.
- To investigate DNA-encoded chemical library technology for novel drug development.
Main Methods:
- Utilizing DNA-encoded chemical libraries for high-throughput screening.
- Identifying small molecule ligands with high affinity and specificity for target proteins.
- Developing next-generation targeted cytotoxics.
Main Results:
- DNA-encoded chemical libraries provide access to vast small molecule collections.
- This technology facilitates the identification of potent binding molecules.
- Potential for developing novel targeted cancer therapies.
Conclusions:
- DNA-encoded chemical libraries are a powerful tool for discovering targeted therapeutic ligands.
- Small molecule ligands show promise for overcoming limitations of antibody-based delivery.
- This approach could lead to more effective and less toxic cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:28Inhibitors of Bacterial DNA Synthesis
93
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
93
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K